| Literature DB >> 31422502 |
Rasheed Omobolaji Alabi1, Mohammed Elmusrati1, Iris Sawazaki-Calone2, Luiz Paulo Kowalski3, Caj Haglund4,5, Ricardo D Coletta6, Antti A Mäkitie7,8,9, Tuula Salo10,11,12, Ilmo Leivo13, Alhadi Almangush14,15,16,17.
Abstract
Estimation of risk of recurrence in early-stage oral tongue squamous cell carcinoma (OTSCC) remains a challenge in the field of head and neck oncology. We examined the use of artificial neural networks (ANNs) to predict recurrences in early-stage OTSCC. A Web-based tool available for public use was also developed. A feedforward neural network was trained for prediction of locoregional recurrences in early OTSCC. The trained network was used to evaluate several prognostic parameters (age, gender, T stage, WHO histologic grade, depth of invasion, tumor budding, worst pattern of invasion, perineural invasion, and lymphocytic host response). Our neural network model identified tumor budding and depth of invasion as the most important prognosticators to predict locoregional recurrence. The accuracy of the neural network was 92.7%, which was higher than that of the logistic regression model (86.5%). Our online tool provided 88.2% accuracy, 71.2% sensitivity, and 98.9% specificity. In conclusion, ANN seems to offer a unique decision-making support predicting recurrences and thus adding value for the management of early OTSCC. To the best of our knowledge, this is the first study that applied ANN for prediction of recurrence in early OTSCC and provided a Web-based tool.Entities:
Keywords: Artificial neural network; Locoregional recurrence; Machine learning; Oral tongue cancer; Prediction
Mesh:
Year: 2019 PMID: 31422502 PMCID: PMC6828835 DOI: 10.1007/s00428-019-02642-5
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064
Fig. 1Structure of ANN with prognostic factors for training the network (WPOI worst pattern of invasion, LHR lymphocytic host response, PNI perineural invasion)
Summary of histopathologic parameters included for neural network analysis and development of the Web-based tool
| Variable | Categories | Definition | Total | Recurrence |
|---|---|---|---|---|
| WHO grade | ||||
| Grade I | Well-differentiated tumor | 105 | 28 | |
| Grade II | Moderately differentiated tumor | 131 | 38 | |
| Grade III | Poorly differentiated tumor | 75 | 23 | |
| Tumor budding* | ||||
| None | There is no tumor budding | 114 | 26 | |
| Low | Tumor has less than five buds | 102 | 24 | |
| High | Tumor has five buds or more at the invasive front | 95 | 39 | |
| Depth of invasion | ||||
| Superficial | Tumor less than 4 mm in depth | 116 | 26 | |
| Deep | Tumor with 4 mm in depth or deeper | 195 | 63 | |
| Worst pattern of invasion (WPOI) | ||||
| Type 1; Type 2; Type 3** | Pushing border; finger-like growth; large tumor islands | 78 | 15 | |
| Type 4 | Small tumor islands (≤ 15 cancer cells) | 190 | 61 | |
| Type 5 | Tumor satellites | 43 | 13 | |
| Lymphocytic host response (LHR) | ||||
| Type 1 | Strong | 53 | 16 | |
| Type 2 | Intermediate | 116 | 35 | |
| Type 3 | Weak | 142 | 38 | |
| Perineural invasion (PNI) | ||||
| Absent | PNI was not observed | 269 | 73 | |
| Present | PNI was observed | 42 | 16 | |
*Tumor budding defined as a single cancer cell or cancer cluster of four cancer cells or less
**Types 1, 2, and 3 of worst pattern of invasion were considered in one risk group
Fig. 2The network training performance measure using cross-entropy
Fig. 3The ROC curve of the trained network in MATLAB
Fig. 4a Error histogram showing the difference between the targets and outputs. b An indicative receiver operating characteristics (ROC) curve from Azure for the Web deployment
The overall performance measures of the network
| Software | Performance measures for the training of the network | ||||
|---|---|---|---|---|---|
| MATLAB | 0.24471 Network performance error | 92.7% Accuracy | |||
| Azure Machine Learning (ML) Studio | 88.2% Accuracy | 71.2% Sensitivity | 98.9% Specificity | 0.824 F1 Score | 97.3% C-index/AUC |
97.7% Positive predictive value (PPV) | 84.5% Negative predictive value (NPV) | ||||
The performance of the Web-based tool on the newly tested cases
| Patients with OTSCC | ||||
|---|---|---|---|---|
| Web-based tool for the prediction of OTSCC recurrences | High-risk OTSCC recurrences | Low-risk OTSCC recurrences | Total | Other performance metrics |
15 True positive | 7 False positive | 22 Total_Test-positive | 68.2% Positive predictive value (PPV) | |
4 False negative | 33 True negative | 37 Total_Test-negative | 89.2% Negative predictive value (NPV) | |
19 Total_High-risk OTSCC recurrences | 40 Total_Low-risk OTSCC recurrences | 59 Total_Test-cases | 4.5/0.35 Positive/negative likelihood ratios | |
78.9% Sensitivity | 82.5% Specificity | |||